image
Legend Biotech Corporation LEGN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 38.19
-4.26 %
$ 7.32 B
Market Cap
-19.89
P/E
CASH FLOW STATEMENT
-393 M OPERATING CASH FLOW
-96.61%
Growth Rates
1Year -96.61%
3Years -20.82%
5Years -17.90%
7Years 0.00%
10Years 0.00%
92.8 M INVESTING CASH FLOW
218.43%
Growth Rates
1Year 218.43%
3Years 80.07%
5Years 23.79%
7Years 0.00%
10Years 0.00%
791 M FINANCING CASH FLOW
109.40%
Growth Rates
1Year 109.40%
3Years 8.55%
5Years 216.28%
7Years 0.00%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Legend Biotech Corporation
image
Net Income -518 M
Depreciation & Amortization 20.5 M
Capital Expenditures -22.7 M
Stock-Based Compensation 47.7 M
Change in Working Capital -71.3 M
Others 181 M
Free Cash Flow -416 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
OPERATING CASH FLOW
Net Income (518.3) (445.7) (386.2) (307.6) (130.4) (1.6) 9.4
Depreciation & Amortization 20.5 18.4 13.9 9.9 5.3 1.7 0.2
Deferred Income Tax 0 0 (174.9) 9.2 (7.4) (5.7) 0
Stock Based Compensation 47.7 34.3 20.2 4.8 1.3 0.7 0
Other Operating Activities 128.2 6.6 187.7 84.6 (4.4) (6.1) 228.9
Change in Working Capital (71.3) 186.3 140.9 (23.9) 52.5 318.7 (16.5)
Cash From Operations (393.3) (200.0) (198.5) (223.0) (83.1) 307.7 (2.4)
INVESTING CASH FLOW
Capital Expenditures (22.7) (22.3) (47.1) (49.8) (39.2) (21.0) (0.9)
Other Items 115.5 (56.1) (147.9) 25.6 (19.5) (81.2) 60 K
Cash From Investing Activities 92.8 (78.3) (195.0) (24.2) (58.7) (102.3) (0.8)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0
Total Debt Repaid (3.8) (2.6) (1.4) (2.6) (5.1) (0.2) 32 K
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 211.6 2.9 4.6 159.4 19.7 2.7 3.4
Cash From Financing Activities 791.5 378.0 626.7 618.9 14.7 2.5 3.3
CHANGE IN CASH
Net Change In Cash 490.8 97.1 233.2 372.3 (126.8) 208.1 0.1
FREE CASH FLOW
Free Cash Flow (416.0) (222.3) (245.6) (272.8) (122.2) 286.7 (3.3)